Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Tuberous Sclerosis 3Epilepsy 1Child Development Disorders, Pervasive 1Autistic Disorder 1

Interventions

Everolimus 18Sirolimus 15Cannabidiol 5radiprodil 3ganaxolone 3Vigabatrin 3Activator Appliances 3Melatonin 2exemestane 1dactolisib 1carbon-11 acetate 1Surveys and Questionnaires 1Simvastatin 1Sertraline 1Selective Serotonin Reuptake Inhibitors 1Propranolol 1Itraconazole 1Injections 1Fluid Therapy 1Doxycycline 1Curcumin 1Carbamazepine 1Calcitriol 1Aspirin 1Anticonvulsants 1Actigraphy 1Acceptance and Commitment Therapy 12-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Tuberous Sclerosis × Activator Appliances × Clear all
NCT04698538 2024-10-30

TRAIN

University of California, Los Angeles

Phase NA Completed
54 enrolled

Tuberous Sclerosis

NCT03422367 2020-11-06

JETS

University of California, Los Angeles

Phase NA Unknown
64 enrolled

Autistic Disorder, Child Development Disorders, Pervasive, Epilepsy, Tuberous Sclerosis

NCT02687633 2018-05-02

Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex

University of California, Los Angeles

Phase NA Completed
8 enrolled

Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡